FT. LAUDERDALE, FL--(Marketwire - January 07, 2008) - OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that following a rigorous evaluation of six electronic data capture vendors, OmniComm’s TrialMaster software was selected by Valeant Pharmaceuticals as its first choice for EDC. The initial vendor evaluation began with six EDC companies that quickly narrowed down to two major players. TrialMaster’s user-friendly, intuitive and feature rich functionality were important elements in the final decision, but OmniComm’s customer referrals for superior service and customer support became the deciding factor.
